Author Archives: clinicalaccelerator
Patient Enrollment Begins in Everolimus Drug-Coated Balloon Study
Below, we are re-publishing with permission the press-release issued by Cardiovascular Systems Inc. on September 02, 2022 Cardiovascular Systems has an acquisition option agreement with the balloon’s developer, Chansu Vascular Technologies. Cardiovascular Systems Inc. (CSI) has begun enrolling patients in its … Continue reading
Posted in Cardiology, Medical Devices
Leave a comment
Live in the OR Interview Anteris CEO Wayne Paterson
Interview with the implanting physicians from the DurAVR First-in-Human Study
Posted in Cardiology, Medical Devices
Leave a comment
Clinical Accelerator announces collaboration with CryoTherapuetics – a medical device company focused on treating coronary artery disease
Clinical Accelerator, a full-service, medical device focused contract research organization, is pleased to announce a new partnership with CryoTherapeutics – an early-stage European medical device company which has developed a novel cryoenergy therapy for the treatment of inflamed atherosclerotic plaque, … Continue reading
Posted in Clinical Accelerator, Medical Devices
Leave a comment
Newly Published Chronic Heart Failure Treatment Study Provides Promising Results for EVBA Procedure with Unique MobiusHD Device
Below, we are re-publishing with permission the press-release issued by Vascular Dynamics, Inc. on October 18, 2022 Vascular Dynamics, Inc. (VDI), a privately held medical device company focused on developing game-changing endovascular device-based solutions for patients suffering from heart failure, … Continue reading
Posted in Cardiology, Medical Devices
Leave a comment
Miracor Medical Announces FDA IDE Approval For PiCSO® Pivotal Study
Below, we are re-publishing with permission the press-release issued by Miracor Medical on August 23, 2022 AWANS, Belgium–(BUSINESS WIRE)–Miracor Medical SA (Miracor Medical) has announced the approval of an Investigational Device Exemption (IDE) from the FDA, enabling the company to … Continue reading
Posted in Cardiology, Medical Devices, Uncategorized
Leave a comment
Sequana Medical announces positive top-line results from SAHARA Ph. 2a study of DSR 1.0 in diuretic-resistant heart failure patients with persistent congestion and first patient dosed successfully with DSR 2.0 in YUKON
Below, we are re-publishing with permission the press-release issued by Sequana Medical on November 15, 2022 15 November 2022, 07:00 am CET Ghent, Belgium – 15 November 2022 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the treatment of … Continue reading
Posted in Cardiology, Medical Devices
Leave a comment
Maxwell Biomedical Completes First-in-Human Study Enrollment and Testing of Spatial Resynchronization™ Therapy
Below, we are re-publishing with permission the press-release issued by Maxwell Biomedical on October 20, 2022 Spatial Resynchronization Therapy (SR™T) demonstrates proof-of-concept in repeatedly terminating atrial fibrillation (AFib) and restoring sinus rhythm SAN DIEGO, CALIFORNIA, UNITED STATES, October 20, 2022 … Continue reading
Posted in Cardiology, Medical Devices
Leave a comment
Axon Therapies Announces Positive Early Clinical Data from REBALANCE-HF Randomized Clinical Trial
Below, we are re-publishing with permission the press-release issued by Axon Therapies on May 26, 2022 Late-breaking results presented at the European Society of Cardiology’s Heart Failure Association annual conference and simultaneously published online in the European Journal of Heart … Continue reading
Posted in Cardiology, Medical Devices
Leave a comment
Maxwell Biomedical Receives NIH Small Business Innovation Research Grant
Below, we are re-publishing with permission the press-release issued by Maxwell Biomedical on September 15, 2022 Grant money will be used to support the research and development of Spatial Resynchronization™ Therapy (SR™T) to treat atrial fibrillation (AFib) SAN DIEGO, Calif., … Continue reading
Posted in Cardiology
Leave a comment
AtriAN Medical Completes Enrollment of Second Study on Cardioneuroablation using PFA
Below, we are re-publishing with permission the press-release issued by AtriAN Medical on September 06, 2022 This follow-up trial builds on AtriAN’s initial safety and feasibility study and aims to assess the efficacy of its cardioneuroablation treatment in patients with atrial … Continue reading
Posted in Cardiology, Medical Devices
Leave a comment
clinicalaccelerator.com 
You must be logged in to post a comment.